Former CDC Director Warns of Eroding Trust in Science in New Interview
Turn Therapeutics Inc., a biotech company specializing in dermatology, wound care, and infectious disease treatments, has been making waves. Its CEO, Brad Burnam, recently sat down with Dr. Robert Redfield, former CDC Director, to discuss healthcare communication and rebuilding public trust in science. The interview, 'Redfield's Warning: Former CDC Director on COVID's Biggest Casualty-Trust in Science,' is now available on major podcast platforms, YouTube, and the company's IR website.
Turn Therapeutics, with three FDA clearances for its proprietary formulations, is advancing late-stage clinical programs in eczema and onychomycosis. It's also exploring global health initiatives like thermostable vaccine delivery. Brad Burnam, the company's founder and CEO, expressed his pleasure in speaking with Dr. Redfield, a virologist who served as CDC Director from 2018 to 2021. Dr. Redfield, a strong advocate for science-based decision-making, discussed the impact of COVID-19 on public trust in science.
Following Dr. Redfield's resignation, Dr. Rochelle Walensky served as CDC Director from 2021 until 2023. After her departure, Nirav Dinesh Shah served as acting director in 2023, succeeded by Mandy Cohen.
Turn Therapeutics' CEO, Brad Burnam, has taken a step towards fostering dialogue and trust in science by engaging with Dr. Robert Redfield. The company continues to advance its clinical programs and global health initiatives, demonstrating its commitment to improving healthcare communication and public trust in science.
